Publications of Matthias Fischer

Journal Article (13)

1.
Journal Article
Koach, J.; Holien, J. K.; Massudi, H.; Carter, D. R.; Ciampa, O. C.; Herath, M.; Lim, T.; Seneviratne, J. A.; Milazzo, G.; Murray, J. E. et al.; McCarroll, J. A.; Liu, B.; Mayoh, C.; Keenan, B.; Stevenson, B. W.; Gorman, M. A.; Bell, J. L.; Doughty, L.; Hüttelmaier, S.; Oberthuer, A.; Fischer, M.; Gifford, A. J.; Liu, T.; Zhang, X.; Zhu, S.; Gustafson, W. C.; Haber, M.; Norris, M. D.; Fletcher, J. I.; Perini, G.; Parker, M. W.; Cheung, B. B.; Marshall, G. M.: Drugging MYCN oncogenic signaling through the MYCN-PA2G4 binding interface. Cancer Research: an official organ of the American Association for Cancer Research 79 (21), pp. 5652 - 5667 (2019)
2.
Journal Article
Geoerger, B.; Bourdeaut, F.; DuBois, S. G.; Fischer, M.; Geller, J. I.; Gottardo, N. G.; Marabelle, A.; Pearson, A. D.J.; Modak, S.; Cash, T. et al.; Robinson, G. W.; Motta, M.; Matano, A.; Bhansali, S. G.; Dobson, J. R.; Parasuraman, S.; Chi, S. N.: A phase I study of the CDK4/6 inhibitor ribociclib (LEE011) in pediatric patients with malignant rhabdoid tumors, neuroblastoma, and other solid tumors. Clinical Cancer Research 23 (10), pp. 2433 - 2441 (2017)
3.
Journal Article
Layer, J. P.; Kronmüller, M. T.; Quast, T.; van den Boorn-Konijnenberg, D.; Effern, M.; Hinze, D.; Althoff, K.; Schramm, A.; Westermann, F.; Peifer, M. et al.; Hartmann, G.; Tüting, T.; Kolanus, W.; Fischer, M.; Schulte, J. H.; Hölzel, M.: Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression. Oncoimmunology 6 (3), e1320626 (2017)
4.
Journal Article
Lodrini, M.; Sprüssel, A.; Astrahantseff, K.; Tiburtius, D.; Konschak, R.; Lode, H. N.; Fischer, M.; Keilholz, U.; Eggert, A.; Deubzer, H. E.: Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. Oncotarget 8 (49), pp. 85234 - 85251 (2017)
5.
Journal Article
Damm-Welk, C.; Siddiqi, F.; Fischer, M.; Hero, B.; Narayanan, V.; Camidge, D. R.; Harris, M.; Burke, A.; Lehrnbecher, T.; Pulford, K. et al.; Oschlies, I.; Siebert, R.; Turner, S.; Woessmann, W.: Anti-ALK antibodies in patients with ALK-positive malignancies not expressing NPM-ALK. Journal of Cancer 7 (11), pp. 1383 - 1387 (2016)
6.
Journal Article
Fabian, J.; Opitz, D.; Althoff, K.; Lodrini, M.; Hero, B.; Volland, R.; Beckers, A.; De Preter, K.; Decock, A.; Patil, N. et al.; Abba, M.; Kopp-Schneider, A.; Astrahantseff, K.; Wünschel, J.; Pfeil, S.; Ercu, M.; Künkele, A.; Hu, J.; Thole, T.; Schweizer, L.; Mechtersheimer, G.; Carter, D. R.; Cheung, B. B.; Popanda, O.; von Deimling, A.; Koster, J.; Versteeg, R.; Schwab, M.; Marshall, G. M.; Speleman, F.; Erb, U.; Zoeller, M.; Allgayer, H.; Simon, T.; Fischer, M.; Kulozik, A. E.; Eggert, A.; Witt, O.; Schulte, J. H.; Deubzer, H. E.: MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma. Oncotarget 7 (41), pp. 66344 - 66359 (2016)
7.
Journal Article
Formicola, D.; Petrosino, G.; Lasorsa, V. A.; Pignataro, P.; Cimmino, F.; Vetrella, S.; Longo, L.; Tonini, G. P.; Oberthuer, A.; Iolascon, A. et al.; Fischer, M.; Capasso, M.: An 18 gene expression‑based score classifier predicts the clinical outcome in stage 4 neuroblastoma. Journal of Translational Medicine 14 (1), 142 (2016)
8.
Journal Article
Hertwig, F.; Peifer, M.; Fischer, M.: Telomere maintenance is pivotal for high-risk neuroblastoma. Cell Cycle 15 (3), pp. 311 - 312 (2016)
9.
Journal Article
Ikram, F.; Ackermann, S.; Kahlert, Y.; Volland, R.; Roels, F.; Engesser, A.; Hertwig, F.; Kocak, H.; Hero, B.; Dreidax, D. et al.; Henrich, K.-O.; Berthold, F.; Nürnberg, P.; Westermann, F.; Fischer, M.: Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma. Molecular Oncology 10 (2), pp. 344 - 359 (2016)
10.
Journal Article
Ribeiro, D.; Klarqvist, M. D.R.; Westermark, U. K.; Oliynyk, G.; Dzieran, J.; Kock, A.; Banares, C. S.; Hertwig, F.; Johnsen, J. I.; Fischer, M. et al.; Kogner, P.; Loven, J.; Henriksson, M. A.: Regulation of nuclear hormone receptors by MYCN-driven miRNAs impacts neural differentiation and survival in neuroblastoma patients. Cell Reports 16 (4), pp. 979 - 993 (2016)
11.
Journal Article
Worst, B. C.; van Tilburg, C.; Balasubramanian, G. P.; Fiesel, P.; Witt, R.; Freitag, A.; Boudalil, M.; Previti, C.; Wolf, S.; Schmidt, S. et al.; Chotewutmontri, S.; Bewerunge-Hudler, M.; Schick, M.; Schlesner, M.; Hutter, B.; Taylor, L.; Borst, T.; Sutter, C.; Bartram, C. R.; Milde, T.; Pfaff, E.; Kulozik, A. E.; von Stackelberg, A.; Meisel, R.; Borkhardt, A.; Reinhardt, D.; Klusmann, J.-H.; Fleischhack, G.; Tippelt, S.; Dirksen, U.; Jürgens, H.; Kramm, C. M.; von Bueren, A. O.; Westermann, F.; Fischer, M.; Burkhardt, B.; Wößmann, W.; Nathratha, M.; Bielacka, S. S.; Frühwald, M. C.; Fulda, S.; Klingebiel, T.; Koscielniak, E.; Schwab, M.; Tremmel, R.; Driever, P. H.; Schulte, J. H.; Brors, B.; von Deimling, A.; Lichter, P.; Eggert, A.; Capper, D.; Pfister, S. M.; Jones, D. T.W.; Witt, O.: Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study. European Journal of Cancer 65, pp. 91 - 101 (2016)
12.
Journal Article
Carter, D. R.; Murray , J.; Cheung, B. B.; Gamble, L.; Koach, J.; Tsang, J.; Sutton, S.; Kalla, H.; Syed, S.; Gifford, A. J. et al.; Issaeva, N.; Biktasova, A.; Atmadibrata, B.; Sun, Y.; Sokolowski, N.; Ling, D.; Kim, P. Y.; Webber, H.; Clark, A.; Ruhle, M.; Liu, B.; Oberthuer, A.; Fischer, M.; Byrne, J.; Saletta, F.; Thwe, L. M.; Purmal, A.; Haderski, G.; Burkhart, C.; Speleman, F.; De Preter, K.; Beckers, A.; Ziegler, D. S.; Liu, T.; Gurova, K.; Gudkov, A. V.; Norris, M. D.; Haber, M.; Marshall, G. M.: Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma. Science Translational Medicine 7 (312), 312ra176 (2015)
13.
Journal Article
Fey, D.; Halasz, M.; Dreidax, D.; Kennedy, S. P.; Hastings, J. F.; Rauch, N.; Munoz, A. G.; Pilkington, R.; Fischer, M.; Westermann, F. et al.; Kolch, W.; Kholodenko, B. N.; Croucher, D. R.: Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients. Science Signaling 8 (408), ra130 (2015)
Go to Editor View